T1D Exchange has made an investment of an undisclosed amount in artificial pancreas startup Admetsys as part of its initiative to support automated insulin delivery technology development. An Automated Insulin Delivery system has been developed by Admetsys to allow for more effective blood glucose control in hospitals and surgical centers.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.